Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1940 1
1946 1
1947 2
1950 1
1951 2
1953 1
1954 4
1955 2
1956 1
1957 2
1958 1
1959 2
1960 1
1961 4
1962 3
1963 4
1964 5
1965 3
1966 2
1967 5
1968 7
1969 7
1970 4
1971 13
1972 10
1973 9
1974 16
1975 27
1976 34
1977 14
1978 14
1979 20
1980 15
1981 22
1982 47
1983 37
1984 38
1985 37
1986 61
1987 43
1988 47
1989 52
1990 70
1991 52
1992 68
1993 49
1994 46
1995 48
1996 54
1997 60
1998 72
1999 81
2000 122
2001 132
2002 134
2003 160
2004 201
2005 196
2006 208
2007 258
2008 271
2009 291
2010 332
2011 330
2012 418
2013 452
2014 672
2015 721
2016 822
2017 839
2018 994
2019 1221
2020 1413
2021 1555
2022 1775
2023 1468
2024 607

Text availability

Article attribute

Article type

Publication date

Search Results

13,829 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Altoobaji
Page 1
Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
Fontana L, Perlin DS, Zhao Y, Noble BN, Lewis JS, Strasfeld L, Hakki M. Fontana L, et al. Clin Infect Dis. 2020 Feb 14;70(5):723-730. doi: 10.1093/cid/ciz282. Clin Infect Dis. 2020. PMID: 30958538 Free PMC article.
CONCLUSIONS: Although ISA has been approved for treatment of invasive Aspergillus and mucormycosis, we observed an increased rate of bIFI, notably IPA, using ISA for primary prophylaxis. These results support the need for further study to determine the role of IS …
CONCLUSIONS: Although ISA has been approved for treatment of invasive Aspergillus and mucormycosis, we observed an increased rate of …
Voclosporin.
[No authors listed] [No authors listed] 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 34699156 Free Books & Documents. Review.
Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma.
Banerjee R, Lo M, Martin TG 3rd. Banerjee R, et al. Future Oncol. 2021 Dec;17(35):4849-4860. doi: 10.2217/fon-2021-0778. Epub 2021 Sep 23. Future Oncol. 2021. PMID: 34553603 Review.
In this review we discuss the rationale and clinical trial experience to date with Isa-Kd. Although final IKEMA results are pending, Isa-Kd has emerged as an effective and tolerable therapy for patients with relapsed multiple myeloma. ...In this review, we discuss p …
In this review we discuss the rationale and clinical trial experience to date with Isa-Kd. Although final IKEMA results are pending, …
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases.
Zhang T, Shen Y, Feng S. Zhang T, et al. Front Cell Infect Microbiol. 2022 Dec 1;12:1049959. doi: 10.3389/fcimb.2022.1049959. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36530445 Free PMC article. Review.
The aim of this review is to summarize the recent real-world experiences of using ISA for the treatment and prevention of IFD. METHODS: We performed a comprehensive literature search of the MEDLINE, PubMed, Embase, and Cochrane databases for clinical applications of ISA …
The aim of this review is to summarize the recent real-world experiences of using ISA for the treatment and prevention of IFD. METHOD …
ISA API: An open platform for interoperable life science experimental metadata.
Johnson D, Batista D, Cochrane K, Davey RP, Etuk A, Gonzalez-Beltran A, Haug K, Izzo M, Larralde M, Lawson TN, Minotto A, Moreno P, Nainala VC, O'Donovan C, Pireddu L, Roger P, Shaw F, Steinbeck C, Weber RJM, Sansone SA, Rocca-Serra P. Johnson D, et al. Gigascience. 2021 Sep 16;10(9):giab060. doi: 10.1093/gigascience/giab060. Gigascience. 2021. PMID: 34528664 Free PMC article.
To make the ISA framework more accessible to machines and enable programmatic manipulation of experiment metadata, the JSON serialization ISA-JSON was developed. RESULTS: In this work, we present the ISA API, a Python library for the creation, editing, parsin …
To make the ISA framework more accessible to machines and enable programmatic manipulation of experiment metadata, the JSON serializa …
ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
[No authors listed] [No authors listed] Drugs R D. 2007;8(2):103-12. doi: 10.2165/00126839-200708020-00005. Drugs R D. 2007. PMID: 17324008 Review.
The combination of reduced toxicity and improved potency would give ISA 247 a therapeutic benefit over existing calcineurin-based treatments. ...Half of the patients were treated with ciclosporin and the other half received ISA 247 over a 90-day period. An extension …
The combination of reduced toxicity and improved potency would give ISA 247 a therapeutic benefit over existing calcineurin-based tre …
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis.
Facon T, Moreau P, Baker R, Min CK, Leleu X, Mohty M, Karlin L, Armstrong NM, Tekle C, Schwab S, Risse ML, Martin T. Facon T, et al. Haematologica. 2024 Feb 1;109(2):604-616. doi: 10.3324/haematol.2023.283073. Haematologica. 2024. PMID: 37584290 Free PMC article. Clinical Trial.
This IKEMA subgroup analysis examined efficacy and safety of Isa-Kd versus Kd in patients who experienced early (n=61 [Isa-Kd], n=46 [Kd]) vs. late relapse (n=104 [Isa-Kd], n=72 [Kd]). ...Grade 3, serious treatment-emergent adverse events, and death rates wer …
This IKEMA subgroup analysis examined efficacy and safety of Isa-Kd versus Kd in patients who experienced early (n=61 [Isa-Kd] …
ISA implementation and uncertainty: a literature review and expert elicitation study.
van der Pas JW, Marchau VA, Walker WE, van Wee GP, Vlassenroot SH. van der Pas JW, et al. Accid Anal Prev. 2012 Sep;48:83-96. doi: 10.1016/j.aap.2010.11.021. Epub 2011 Jan 16. Accid Anal Prev. 2012. PMID: 22664671 Review.
Experts indicate that there are still too many uncertainties surrounding ISA implementation, and dealing with these uncertainties is essential for implementing ISA. ...We found that the long-term effects and the effects of large-scale implementation of ISA ar …
Experts indicate that there are still too many uncertainties surrounding ISA implementation, and dealing with these uncertainties is …
Intracellular Self-Assembly of Peptide Conjugates for Tumor Imaging and Therapy.
Deng Y, Zhan W, Liang G. Deng Y, et al. Adv Healthc Mater. 2021 Jan;10(1):e2001211. doi: 10.1002/adhm.202001211. Epub 2020 Sep 9. Adv Healthc Mater. 2021. PMID: 32902191 Review.
Therefore, the recent progress of ISA of peptide conjugates is summarized in this progress report. Moreover, several examples of ISA of peptide conjugates for other important imaging or therapeutic applications are also introduced. ...
Therefore, the recent progress of ISA of peptide conjugates is summarized in this progress report. Moreover, several examples of I …
Population Pharmacokinetics of Isavuconazole in Adult: A Systematic Review.
Chen N, Wang X, Li Y, Yang P, Huang M, Lu X. Chen N, et al. Infect Drug Resist. 2023 Dec 8;16:7559-7568. doi: 10.2147/IDR.S434622. eCollection 2023. Infect Drug Resist. 2023. PMID: 38089964 Free PMC article. Review.
In recent years, population pharmacokinetic studies of ISA have been reported continuously. This paper aims to summarize the characteristics of population pharmacokinetic models of ISA in adults, and provide theoretical basis for individualized administration of …
In recent years, population pharmacokinetic studies of ISA have been reported continuously. This paper aims to summarize the characte …
13,829 results
You have reached the last available page of results. Please see the User Guide for more information.